Eli Lilly, Food and Drug Administration
Why Eli Lilly could be the real weight loss drug winner
It has the most potent weight-loss shot and a large experimental pipeline, including what is widely expected to be the first approved small molecule GLP-1 pill.
Eli Lilly’s weight-loss drug no longer in shortage, FDA says
The two-year shortage of Eli Lilly’s blockbuster weight-loss and diabetes drugs is over, the U.S. Food and Drug Administration announced Wednesday.
What end of Eli Lilly's weight-loss drug shortage means for the competition
The US Food and Drug Administration confirmed Thursday that Eli Lilly (LLY) has increased production of its blockbuster weight-loss drug Zepbound and type 2 diabetes drug Mounjaro, implying the company can now supply enough doses to meet current demand.
Inside Eli Lilly's fight against counterfeit drugs
"GMA" shares an exclusive look inside the lab of the maker of such drugs as Mounjaro and Zepbound to show what it's doing to warn users about the dangers of counterfeit drugs.
Eli Lilly to Invest $4.5 Billion to Open New Drug Manufacturing, Development Center
Eli Lilly (LLY) announced a $4.5 billion investment on Wednesday to open a new manufacturing and development center that will support treatments from research stages through their entry into clinical trials.
Eli Lilly (NYSE:LLY) to Build $4.5 Billion Research and Manufacturing Center
Pharmaceutical company Eli Lilly ($LLY) says it will spend $4.5 billion to create a new research and manufacturing center for the development of
Lilly Weight-Loss Drug Copycat Makers Sue FDA Over Shortage End
A group representing companies that made copycat versions of Eli Lilly & Co.’s weight-loss drugs sued the US Food and Drug ...
Billion-Dollar News for Eli Lilly Stock Investors
Eli Lilly shares have soared thanks to excitement about the company's position in the weight loss drug market.
Compounding group sues FDA for removing Lilly's weight loss drug from shortage list
A drug compounding industry group on Monday sued the U.S. Food and Drug Administration over its decision to take Eli Lilly’s ...
Eli Lilly’s Weight-Loss Drugs Are No Longer in Short Supply. Bad News for Hims & Hers.
Blockbuster drugs Zepbound and Mounjaro have come off the FDA's shortage list. Shares of Hims & Hers, which had capitalized ...
Eli Lilly plans $4.5 billion facility in LEAP District, bringing investment to $13 billion
The $4.5 billion investment will create the Lilly Medicine Foundry, a center that will combine research and manufacturing ...
Hoodline3d
Texas AG Ken Paxton Sues Eli Lilly and Major PBMs, Alleging Insulin Price Gouging Conspiracy
Texas is suing insulin manufacturers and PBMs, including Eli Lilly and CVS Pharmacy, alleging a scheme to hike insulin prices ...
FiercePharma5d
High-flying Eli Lilly pushes more chips forward with $4.5B 'Medicine Foundry' project
As Eli Lilly has surged to become the most valuable company in biopharma—with a market cap now more than twice that of ...
This IPO Biotech Stock Could Be the Next Eli Lilly
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.